{
    "Trade/Device Name(s)": [
        "Elecsys Rubella IgG Immunoassay",
        "Elecsys Rubella IgG PreciControl"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K072617",
    "Predicate Device Reference 510(k) Number(s)": [
        "K983805",
        "K984180"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LFX",
        "JJX"
    ],
    "Summary Letter Date": "December 5, 2008",
    "Summary Letter Received Date": "November 14, 2008",
    "Submission Date": "November 13, 2008",
    "Regulation Number(s)": [
        "21 CFR 866.3510"
    ],
    "Regulation Name(s)": [
        "ELISA, Rubella"
    ],
    "Analyte Class(es)": [
        "virology",
        "immunology",
        "serology"
    ],
    "Analyte(s)": [
        "Rubella IgG antibody"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Lithium heparin plasma",
        "Potassium EDTA plasma",
        "Sodium citrate plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Elecsys 2010",
        "cobas e 411",
        "MODULAR ANALYTICS E170 (Elecsys module)",
        "cobas e 601"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescence immunoassay (ECLIA)",
        "Sandwich immunoassay"
    ],
    "Methodologies": [
        "Quantitative immunoassay",
        "Electrochemiluminescence detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Quality Control Material"
    ],
    "Document Summary": "FDA 510(k) summary for Elecsys Rubella IgG Immunoassay and PreciControl for quantitation and QC of rubella IgG antibodies using ECLIA on Elecsys and cobas e analyzers",
    "Indications for Use Summary": "For in vitro quantitative determination of IgG antibodies to rubella virus in human serum and plasma; aids in assessment of immune status to rubella in individuals including women of childbearing age; PreciControl used for quality control of the immunoassay on specified analyzers",
    "fda_folder": "Microbiology"
}